---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014238"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T16:57:46.301075+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Dare Bioscience provides corporate presentation; filing text lacks specific content

## Summary
- Corporate presentation dated June 9, 2025 furnished as Exhibit 99.1.
- Presentation to be used in meetings with market participants and available on company website.
- No specific financial, pipeline, or guidance updates disclosed in the provided filing text.

## SEC filing metadata
- accession: 0001641172-25-014238
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000164117225014238/0001641172-25-014238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000164117225014238/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014238
- JSON: https://secwatch.observer/filing/0001641172-25-014238.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.